Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00862095 · ClinicalTrials.gov registry record · Phase 4
Medical Therapies for Chronic Post-Traumatic Headaches
A Phase 4 study, sponsored by Madigan Army Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT00862095 is a Phase 4 study that was terminated before completion, run by Madigan Army Medical Center. The registered enrollment target is 64 participants.
The verdict
NCT00862095, a Phase 4 study, was terminated before completion, sponsored by Madigan Army Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
To determine if propranolol, amitriptyline, or topiramate decreases headache frequency in patients with chronic post-traumatic headaches.
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Amitriptyline
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00862095
The ClinicalTrials.gov registry entry for NCT00862095 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00862095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00862095 about?
NCT00862095 is a clinical study titled "Medical Therapies for Chronic Post-Traumatic Headaches". To determine if propranolol, amitriptyline, or topiramate decreases headache frequency in patients with chronic post-traumatic headaches.
What is the current status of trial NCT00862095?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2008-06. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00862095?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Amitriptyline (DRUG), Topiramate (DRUG).
Who is sponsoring clinical trial NCT00862095?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.